These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3567923)

  • 21. Therapeutic response of human tumor xenografts in athymic mice to doxorubicin.
    Giuliani FC; Zirvi KA; Kaplan NO
    Cancer Res; 1981 Jan; 41(1):325-35. PubMed ID: 7448772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.
    Alvarez M; Paull K; Monks A; Hose C; Lee JS; Weinstein J; Grever M; Bates S; Fojo T
    J Clin Invest; 1995 May; 95(5):2205-14. PubMed ID: 7738186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil.
    Zhang L; Yang Y; Wei XY; Shi YR; Liu HY; Niu RF; Hao XS
    J Exp Clin Cancer Res; 2007 Jun; 26(2):201-7. PubMed ID: 17725099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.
    Dantzig AH; Shepard RL; Cao J; Law KL; Ehlhardt WJ; Baughman TM; Bumol TF; Starling JJ
    Cancer Res; 1996 Sep; 56(18):4171-9. PubMed ID: 8797588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro modulation of adriamycin-induced cytotoxicity of fulerol C60(OH)24].
    Puhaca B
    Med Pregl; 1999; 52(11-12):521-6. PubMed ID: 10748779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug resistance and its counteraction by cyclosporin A in function of metastatic potential in the Lewis lung carcinoma system.
    Michowitz M; Dayan-Avidan G; Bar-Shira-Maymon B; Donin N; Leibovici J
    Cell Mol Biol (Noisy-le-grand); 1994 Jun; 40(4):551-60. PubMed ID: 8061572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of doxorubicin resistance in P388/ADR cells by Ro44-5912, a tiapamil derivative.
    De Jong G; Gelmon K; Bally M; Goldie J; Mayer L
    Anticancer Res; 1995; 15(3):911-6. PubMed ID: 7645981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.
    Hyafil F; Vergely C; Du Vignaud P; Grand-Perret T
    Cancer Res; 1993 Oct; 53(19):4595-602. PubMed ID: 8402633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of models in "target" theory to evaluate the survival curves of human ovarian carcinoma cell line exposure to adriamycin combined with ultrasound.
    Yu T; Xiong Z; Chen S; Tu G
    Ultrason Sonochem; 2005 Apr; 12(5):345-8. PubMed ID: 15590307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R; Reiter W; Krishan A
    J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of doxorubicin efficacy in P388 leukemia following co-administration of verapamil in mini-osmotic pumps.
    Slate DL; Fraser-Smith EB; Rosete JD; Freitas VR; Kim YN; Casey SM
    In Vivo; 1993; 7(6A):519-23. PubMed ID: 8193270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A newly synthesized bifunctional inhibitor, CKA1083, enhances adriamycin activity against human ovarian carcinoma cells.
    Maeda O; Kikkawa F; Tamakoshi K; Obata NH; Mizuno K; Suganuma N; Tomoda Y; Kuzuya K; Ishikawa T; Hidaka H
    Anticancer Res; 1997; 17(3C):1985-92. PubMed ID: 9216655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells.
    Vadgama JV; Wu Y; Shen D; Hsia S; Block J
    Anticancer Res; 2000; 20(3A):1391-414. PubMed ID: 10928049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ornithine decarboxylase--a predictor for tumor chemosensitivity.
    Bachrach U; Shayovitz A; Marom Y; Ramu A; Ramu N
    Cell Mol Biol (Noisy-le-grand); 1994 Nov; 40(7):957-64. PubMed ID: 7849562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
    Lepri E; Menconi E; Barzi AM
    Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of multidrug resistance to rhodamine-123 selectivity between carcinoma and normal epithelial cells: taxol and vinblastine modulate drug efflux.
    Brouty-Boyé D; Kolonias D; Wu CJ; Savaraj N; Lampidis TJ
    Cancer Res; 1995 Apr; 55(8):1633-8. PubMed ID: 7712466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enhancement of anti-tumor effect of adriamycin by verapamil in a intrahepatic arterial infusion in the rats].
    Shimoda T; Miyazaki M; Utagawa I; Koshikawa H; Ito H; Okui K
    Nihon Geka Gakkai Zasshi; 1992 May; 93(5):481-7. PubMed ID: 1614393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.